Hiva Saffar; Marzieh Mirzaii; Elham Mirzaian2050@gmail.com; Farid Kosari
Abstract
Background& Objective: Micro-vascular proliferation is an important histological feature of brain glioma with more vascular proliferation is present in higher grades of glioma. CD 105 is expressed in new actively proliferating and immature endothelial cells in tumor environment and appears ...
Read More
Background& Objective: Micro-vascular proliferation is an important histological feature of brain glioma with more vascular proliferation is present in higher grades of glioma. CD 105 is expressed in new actively proliferating and immature endothelial cells in tumor environment and appears to be capable to distinguish between malignant neo-vasculature and normal vessels. Methods: This study was designed to evaluate the Micro-Vessel Density(MVD) in different grades of brain glioma based on CD 105 expression by Immunohistochemistry method to determine whether it can be a helpful marker for rumor grading or not. Paraffin blocks of formalin fixed samples of brain astrocytic glioma were retrieved and IHC was performed using anti-CD105 monoclonal mouse antibody. Results: Total number of 48cases of low and high grade astrocytic gliomas were evaluated.We noted that there was a positive correlation between MVD evaluated by CD105 and tumor grade, meaning that expression was significantly greater in tumors with higher grade (P=0.019). Conclusion: We concluded that MVD quantified by CD 105 has positive correlation with tumor grade. Also we think that expression of CD 105 specially in low-grade glioma can serve as a basis for selective treatment option in combination with current standard care .
Hiva Saffar; Maryam Noohi; Seyed Mohammad Tavangar; Hana Saffar; Sima Azimi
Abstract
Background & Objective Angiogenesis is an essential component of tumor growth. Expression of PSMA on the neo-vasculature of many solid tumors, including glioblastoma multi-form, has been determined. The pattern of expression suggests that PSMA may play a functional role in angiogenesis. Methods: ...
Read More
Background & Objective Angiogenesis is an essential component of tumor growth. Expression of PSMA on the neo-vasculature of many solid tumors, including glioblastoma multi-form, has been determined. The pattern of expression suggests that PSMA may play a functional role in angiogenesis. Methods: expression of PSMA in different grades of brain glioma was evaluated by the immunohistochemistry method to determine the probable usefulness of anti-PSMA antibody as complementary target therapy in different grades of glioma. Results: Overall, 72 cases of low (grade I and II) and high (grade III and IV) grade gliomas were evaluated for expression of PSMA. Positive PSMA staining was observed in 12 (33.3%) of high grade and 3 (8.3%) of low grade gliomas. Although, high grade tumors more commonly had positive result for PSMA (P value=0.009), the intensity of staining was significantly stronger in low-grade tumors (P value=0.009). Conclusion: Expression of PSMA in different grades of glioma might provide a basis for further investigations focusing on selective target therapy in combination with the current standard care in all glioma grades, to improve treatment efficacy.
Younes Roohani; Mohammad Reza Hosseinzadeh; Mahmoodreza Khalatbari; Alireza Sadeghipoor; Farid Zaeri; Azimi-Khatibani , Esmail
Volume 5, Issue 2 , March 2010, , Pages 77-82
Abstract
Background and Objectives: Gliomas are the most prevalent primary brain tumors. The purpose of this retrospective cohort study was evaluation of clinical trend and prognosis of patients with brain glioma and effective factors in prognosis. Materials and Methods: Hundred and forty-five patients ...
Read More
Background and Objectives: Gliomas are the most prevalent primary brain tumors. The purpose of this retrospective cohort study was evaluation of clinical trend and prognosis of patients with brain glioma and effective factors in prognosis. Materials and Methods: Hundred and forty-five patients with supratentorial brain glioma, treated in Shahid Mostafa Khomeini & Hazrat-e-Rasool hospitals in Tehran , Iran from March 1999 to August 2005, were studied. Clinical, therapeutic and malignancy grade data were collected. The WHO classification was used for reporting malignancy grade. All patients were pursued until August 2005. Mann-Whitney, Kaplan-Meier, Cox Regression, and Chi-Square test were used for analysis. Results: Median survival was 39.7 weeks for malignancy grade IV. One-year survival rates in malignancy grades of II, III, IV and all patients were 86%, 83%, 40% and 47%, respectively. In multivariate analysis, effective factors in prognosis of all patients above 60 were radiotherapy and malignancy grade IV; and in patients with malignant glioma were age of above 60 and radiotherapy; and in patients with low-grade glioma were motor deficits. Conclusions: Survival rate decreases from malignancy grade II to IV and this reduction is evident in malignancy grade IV. Role of radiotherapy as an effective factor in prognosis in all patients and in malignant glioma is important.
